Growth at Reasonable Price

Results

141

17 new

141 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
INR
US$13.17-5.0%-32.3%US$815.7mUS$23.755.754.5%n/aEnergy
TVTX
US$54.1415.8%275.7%US$5.0bUS$57.299.450.7%n/aPharmaceuticals & Biotech
MDGL
US$499.866.1%76.8%US$11.6bUS$678.7110.259.2%n/aPharmaceuticals & Biotech
LITE
US$869.982.0%883.5%US$68.1bUS$1,111.29154.279.1%n/aTech
SNDX
US$19.048.3%96.5%US$1.6bUS$39.007.868.2%n/aPharmaceuticals & Biotech
PICS
US$10.9916.9%n/aUS$1.4bUS$20.926.222.2%n/aDiversified Financials
AVGO
US$392.901.9%56.4%US$1.9tUS$522.0663.833.4%0.7%Semiconductors
APP
US$479.49-2.7%39.2%US$173.1bUS$648.1041.121.7%n/aSoftware
ARDX
US$5.844.1%61.8%US$1.4bUS$16.303.455.9%n/aPharmaceuticals & Biotech
TYGO
New
US$2.68-9.8%112.7%US$201.9mUS$6.8560.443.3%n/aCapital Goods
AGBK
US$7.168.6%n/aUS$1.1bUS$14.371.329.1%n/aBanks
ALHC
US$21.424.2%48.8%US$4.3bUS$24.92223.639.5%n/aHealthcare
ORCL
US$183.53-8.8%-13.0%US$541.6bUS$252.6431.124.1%1.1%Software
PTHS
US$27.01-1.5%125.1%US$97.4mUS$57.713.465.9%n/aPharmaceuticals & Biotech
URGN
US$32.8117.2%120.6%US$1.6bUS$36.8811.459.5%n/aPharmaceuticals & Biotech
SPRY
US$9.906.9%-37.8%US$963.2mUS$28.809.965.6%n/aPharmaceuticals & Biotech
CAPR
US$27.9510.3%134.1%US$1.5bUS$54.115.864.6%n/aPharmaceuticals & Biotech
COMP
US$9.4018.8%59.1%US$7.0bUS$13.17484.435.1%n/aReal Estate Management and Development
CCEC
New
US$20.55-4.2%-12.5%US$1.3bUS$25.1712.330.9%2.9%Transportation
LKNC.Y
US$30.691.3%-11.0%US$10.1bUS$45.4018.722.0%n/aConsumer Services
ABEO
US$5.655.4%-5.8%US$322.0mUS$19.714.932.9%n/aPharmaceuticals & Biotech
FSUN
US$35.44-2.6%6.3%US$1.7bUS$43.501.454.2%n/aBanks
RCEL
US$3.94-4.4%-25.0%US$120.6mUS$7.181.762.9%n/aPharmaceuticals & Biotech
ZS
US$124.38-0.3%-59.3%US$20.6bUS$193.056.355.9%n/aSoftware
Page 1 of 4